Assessment of anti-TNF efficacy in rheumatoid arthritis -: Is three months sufficient?

被引：0
|
作者：
Pocock, J. M. [1 ]
Oestoer, A. J. [1 ]
机构：
[1] Addenbrookes Hosp, Dept Rheumatol, Cambridge, England
来源：
RHEUMATOLOGY | 2008年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：II42 / II42
页数：1
相关论文
共 50 条
  • [31] THE IMPACT OF ANTI-TNF ON THE WEIGHT OF RHEUMATOID ARTHRITIS PATIENTS
    Alcorn, Nicola
    Tierney, Ann
    Wu, Olivia
    Gilmour, Harper
    Capell, Hillary
    Madhok, Rajan
    RHEUMATOLOGY, 2009, 48 : I63 - I63
  • [32] Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis
    van Schouwenburg, Pauline A.
    Rispens, Theo
    Wolbink, Gerrit Jan
    NATURE REVIEWS RHEUMATOLOGY, 2013, 9 (03) : 164 - 172
  • [33] CLINICAL COMPARISION OF EFFICACY AND SIDE EFFECT PROFILE OF RITUXIMAB AND ANTI-TNF IN RHEUMATOID ARTHRITIS
    Vagadia, Vipul
    RHEUMATOLOGY, 2010, 49 : I95 - I95
  • [34] Monocytes Membrane TNF Expression and Anti-TNF Treatment in Rheumatoid Arthritis
    Paoletti, Audrey
    Rohmer, Julien
    Pascaud, Juliette
    Oumouly, Bineta
    Riviere, Elodie
    Bitoun, Samuel
    Nocturne, Gaetane
    Mariette, Xavier
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [35] ECONOMIC EVALUATION OF RITUXIMAB VERSUS ANTI-TNF IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PREVIOUS FAILURE TO ANTI-TNF IN MEXICO
    Carlos, F.
    Clark, P.
    VALUE IN HEALTH, 2011, 14 (07) : A563 - A563
  • [36] Immunogenicity of anti-TNF biologic agents in the treatment of rheumatoid arthritis
    Mok, Chi Chiu
    Tsai, Wen Chan
    Chen, Der Yuan
    Wei, James Cheng Chung
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (02) : 201 - 211
  • [37] Cutaneous manifestations during anti-TNF therapy in rheumatoid arthritis
    Solau-Gervais, E
    Lebas, D
    Duquesnoy, B
    Delaporte, E
    Flipo, R
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 458 - 458
  • [38] RHEUMATOID ARTHRITIS International disparities in access to anti-TNF therapy
    Emery, Paul
    NATURE REVIEWS RHEUMATOLOGY, 2011, 7 (04) : 197 - 198
  • [39] Predicting response to anti-TNF treatment in rheumatoid arthritis patients
    Atzeni, Fabiola
    Antivalle, Marco
    Pallavicini, Francesca Bobbio
    Caporali, Roberto
    Bazzani, Chiara
    Gorla, Roberto
    Favalli, Ennio Giulio
    Marchesoni, Antonio
    Sarzi-Puttini, Piercarlo
    AUTOIMMUNITY REVIEWS, 2009, 8 (05) : 431 - 437
  • [40] Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs
    Avouac, J.
    Allanore, Y.
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (07) : 1121 - 1128
12345